APA (7th ed.) Citation

Gramatzki, M., Offidani, M., Günther, A., Engelhardt, M., Salvini, M., Montefusco, V., . . . Gay, F. (2019). Carfilzomib, bendamustine, dexamethasone in patients with advanced multiple myeloma: The EMN09 Phase I/II study of the European Myeloma Network. Clinical lymphoma, myeloma & leukemia, 19, e256. https://doi.org/10.1016/j.clml.2019.09.424

Chicago Style (17th ed.) Citation

Gramatzki, Martin, et al. "Carfilzomib, Bendamustine, Dexamethasone in Patients with Advanced Multiple Myeloma: The EMN09 Phase I/II Study of the European Myeloma Network." Clinical Lymphoma, Myeloma & Leukemia 19 (2019): e256. https://doi.org/10.1016/j.clml.2019.09.424.

MLA (9th ed.) Citation

Gramatzki, Martin, et al. "Carfilzomib, Bendamustine, Dexamethasone in Patients with Advanced Multiple Myeloma: The EMN09 Phase I/II Study of the European Myeloma Network." Clinical Lymphoma, Myeloma & Leukemia, vol. 19, 2019, p. e256, https://doi.org/10.1016/j.clml.2019.09.424.